share_log

Cantor Fitzgerald Assumes Alaunos Therapeutics at Overweight, Announces Price Target of $3

Cantor Fitzgerald Assumes Alaunos Therapeutics at Overweight, Announces Price Target of $3

坎託·菲茨傑拉德假設Alaunos Therapeutics處於增持狀態,宣佈目標股價爲3美元
Benzinga Real-time News ·  2022/07/15 08:40

Cantor Fitzgerald analyst Prakhar Agrawal assumes Alaunos Therapeutics (NASDAQ:TCRT) with a Overweight rating and announces Price Target of $3.

坎託·菲茨傑拉德分析師普拉哈爾·阿格勞瓦爾假設Alaunos Therapeutics(納斯達克股票代碼:TCRT)的評級爲增持,並宣佈目標股價爲3美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論